Thrombectomy With the pRESET vs Solitaire Stent Retrievers as First-Line Large Vessel Occlusion Stroke Treatment

Raul G. Nogueira,Donald Lobsien,Joachim Klisch,Daniel Pielenz,Elmar Lobsien,Eric Sauvageau,Nima Aghaebrahim,Markus Möhlenbruch,Dominik Vollherbst,Christian Ulfert,Hormozd Bozorgchami,Wayne Clark,Ryan Priest,Edgar A. Samaniego,Santiago Ortega-Gutierrez,Malik Ghannam,Demetrius Lopes,Joshua Billingsley,Kiffon Keigher,Diogo C. Haussen,Alhamza R. Al-Bayati,Adnan Siddiqui,Elad Levy,Michael Chen,Stephan Munich,Peter Schramm,Tobias Boppel,Sandra Narayanan,Bradley A. Gross,Christian Roth,Tobias Boeckh-Behrens,Ameer Hassan,Johanna Fifi,Ron F. Budzik,Jason Tarpley,Robert M. Starke,Eytan Raz,Gary Brogan,David S. Liebeskind,Ricardo A. Hanel
DOI: https://doi.org/10.1001/jamaneurol.2023.5010
IF: 29.907
2024-02-13
JAMA Neurology
Abstract:This randomized clinical trial evaluates whether thrombectomy for large vessel occlusion stroke with the pRESET stent retriever is noninferior to treatment with the Solitaire stent retriever.
clinical neurology
What problem does this paper attempt to address?